Photo

Photo detail

Lynn Kirkpatrick, Ph.D.,
CEO,
Ensysce Biosciences

Stories this photo appears in:

Ensysce Biosciences Closes SPAC Merger

BIOTECH: Latest Example of San Diego Life Science Cos. Going Public

Ensysce Biosciences is the latest local company to join the public market after closing the merger deal on July 1. The company will be trading its common stock on the Nasdaq under the ticker symbol “ENSC” and warrants under the ticker symbol “ENSCW” on the OTC Market.